Gabapentin Tablet, Film Coated
Product Images NDC 71335-1132

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-1132). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)

This is a mathematical formula used to calculate the creatinine clearance (CLCr) in patients, which is a measure of how well their kidneys are functioning. The formula takes into account the patient's age, weight, and serum creatinine level. The result is adjusted for female patients using a multiplier of 0.85.*

FDA Label Image

Chem Structure (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 01)

FDA Label Image

Figure01 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 02)

The Moan Pain Score is 10. There is a 4-week dose titration period followed by a fixed dose period of 40k. There is also a placebo and Gabapentin of 3600 mg/day. The duration of the study is measured in weeks.*

FDA Label Image

Figure02 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)

This appears to be a chart showing the results of a study on different doses of Gabapentin for pain management over a 4-week period. There are three groups being compared, one receiving a placebo and the others receiving 1800mg/day or 2400mg/day of Gabapentin. The chart shows the mean pain score at baseline and then at 7 different time points over the 4-week period.*

FDA Label Image

Figure03 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)

The text provides information about the proportion of responders with more than 50% reduction in pain score in controlled PHN studies. The figure shows two studies where patients taking the medication had a higher percentage of responders compared to placebo. The text also includes the cost of GBP 3600 for the medication, GBP 1800 for placebo and GBP 2400 for an unknown product. Therefore, the text might be describing a medication used to treat PHN (postherpetic neuralgia) that is effective in reducing pain and more expensive than placebo.*

FDA Label Image

Figure4 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 05)

FDA Label Image

Label (Lbl713351132)

This is a description of a drug package for Neurontin 600mg Tablet manufactured by Vivimed Life Sciences Pvt Ltd. It includes details such as the package being packaged by Bryant Ranck Prepack and the expiration date of the tablets, which is MM/YY. The package also contains the NDC number and the storage instructions for the medication. The text ends with a warning about keeping all drugs out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.